Skip to main content
. 2021 Aug 7;9(2):347–364. doi: 10.1007/s40487-021-00167-z

Fig. 3.

Fig. 3

PRIMA study design. CR complete response, PR partial response, PFS progression-free survival, RECIST Response Evaluation Criteria in Solid Tumours, OD once daily, Plt platelets